Vestnik dermatologii i venerologii
ISSN 0042-4609 (Print)
ISSN 2313-6294 (Online)
Menu
Archives
Home
About the Journal
Editorial Team
Editorial Policies
Author Guidelines
About the Journal
Issues
Search
Current
Articles in press
Archives
Contact
Subscriptions
Editorial board
User
Username
Password
Remember me
Forgot password?
Register
Notifications
View
Subscribe
Search
Search
Search Scope
All
Authors
Title
Abstract
Index terms
Full Text
Browse
By Issue
By Author
By Title
By Sections
Keywords
C. trachomatis
acne
atopic dermatitis
children
cytokines
diagnostics
efficacy
isotretinoin
neurosyphilis
pathogenesis
psoriasis
psoriatic arthritis
rosacea
safety
syphilis
therapy
topical therapy
treatment
акне
атопический дерматит
псориаз
×
User
Username
Password
Remember me
Forgot password?
Register
Notifications
View
Subscribe
Search
Search
Search Scope
All
Authors
Title
Abstract
Index terms
Full Text
Browse
By Issue
By Author
By Title
By Sections
Keywords
C. trachomatis
acne
atopic dermatitis
children
cytokines
diagnostics
efficacy
isotretinoin
neurosyphilis
pathogenesis
psoriasis
psoriatic arthritis
rosacea
safety
syphilis
therapy
topical therapy
treatment
акне
атопический дерматит
псориаз
Home
>
Search
>
Author Details
Author Details
Kokhan, M. M.
Issue
Section
Title
File
Vol 91, No 5 (2015)
Articles
Efficiency and tolerance of acne therapy using system isotretinoin
(Rus)
Vol 92, No 2 (2016)
DRUG TREATMENT IN DERMATOVENEROLOGY
Reasonable selection of a topical therapy for different forms of acne
(Rus)
Vol 92, No 6 (2016)
DRUG TREATMENT IN DERMATOVENEROLOGY
Analysis of methods common topical treatment of the generalized dermatoses in the delivery of the specialized health care in the profile "Dermatology"
(Rus)
Vol 94, No 6 (2018)
DRUG TREATMENT IN DERMATOVENEROLOGY
Experience in the treatment of psoriasis patients using Apremilast, a selective signalling pathway inhibitor
(Rus)
Vol 95, No 2 (2019)
ORIGINAL STUDIES
Netakimab — new IL-17а inhibitor: 12-week results of phase III clinical study BCD-085-7/PLANETA in patients with moderate-tosevere plaque psoriasis
(Rus)
Vol 95, No 3 (2019)
DRUG TREATMENT IN DERMATOVENEROLOGY
Long-term efficacy and safety of netakimab in patients with moderate-to-severe psoriasis. Results of phase II open-label extension clinical study BCD-085-2-ext
(Rus)
Vol 95, No 5 (2019)
DRUG TREATMENT IN DERMATOVENEROLOGY
Certolizumab pegol: new opportunities for treatment of moderate to severe plaque psoriasis
(Rus)
Vol 97, No 5 (2021)
REVIEWS
Revisiting the question of psoriasis classification
(Rus)
This website uses cookies
You consent to our cookies if you continue to use our website.
About Cookies
TOP